Unit 3 of 3 · B.Sc MLS Sem 6

Unit 3: Blood components and quality control

Blood Banking notes · PTU syllabus (BMLS603-18)

3 min read7 topics9 exam questions
On this page
  1. Unit summary
  2. Component preparation: principle
  3. Red cell components
  4. Platelet components
  5. Plasma components
  6. Blood substitutes
  7. Haemapheresis
  8. Quality control in the blood bank
  9. Key terms
  10. Quick revision
  11. Important questions

Unit summary

Separating blood into components gives each patient exactly what they need. This unit covers packed, washed and frozen red cells, platelet-rich plasma, platelet concentrates, fresh and fresh frozen plasma, cryoprecipitate, blood substitutes, apheresis and quality control in the blood bank.

After this unit you can

  • Prepare red cell components
  • Prepare platelet and plasma components
  • Describe blood substitutes and apheresis
  • Apply quality control in the blood bank

PTU syllabus topics

  • Preparation of packed/washed/frozen red cells
  • platelet-rich plasma/concentrate/frozen platelets
  • fresh plasma/FFP/cryoprecipitate
  • blood substitutes
  • haemapheresis for leucocytes
  • platelets and plasma
  • quality control in the blood bank
ComparisonBlood components
Storage
Given for

Packed red cells

2–6 °C, up to 35–42 days

Anaemia, blood loss

Platelet concentrate

20–24 °C with agitation, 5 days

Low platelets, bleeding

Fresh frozen plasma

−30 °C or colder, up to 1 year

Clotting factor deficiency

Cryoprecipitate

−30 °C or colder, up to 1 year

Low fibrinogen, factor VIII

1

Topic 1

Component preparation: principle

  • Whole blood collected in double, triple or quadruple bags is centrifuged; components separate by specific gravity — red cells at the bottom, buffy coat (white cells and platelets) in the middle, plasma on top — and are expressed into satellite bags in a closed system.
ProcessPlatelet-rich plasma method
  1. 1Light spin (e.g., 1,500 g for 5–8 minutes)
  2. 2Express platelet-rich plasma to a satellite bag; red cells remain (add SAGM)
  3. 3Heavy spin of PRP
  4. 4Express platelet-poor plasma (freeze as FFP within 6–8 hours)
  5. 5Leave 50–70 mL plasma with platelets — rest 1 hour, then agitate
2

Topic 2

Red cell components

ComparisonRed cell components
Preparation
Use and storage

Packed red cells

Plasma removed; PCV 65–75% (55–65% with SAGM)

Anaemia; 2–6 °C up to 35–42 days

Washed red cells

Washed with saline to remove plasma

IgA deficiency, repeated allergic reactions; use within 24 hours

Leucoreduced red cells

Filters remove white cells

Prevent febrile reactions, CMV transmission, HLA alloimmunisation

Irradiated red cells

Gamma irradiation

Prevent TA-GvHD in immunocompromised recipients

Frozen red cells

Glycerol cryoprotectant; stored at −65 °C or colder

Rare groups for up to 10 years; deglycerolise before use

  • Dose: one unit raises Hb by about 1 g/dL in an adult.
3

Topic 3

Platelet components

ComparisonPlatelet components
Description
Storage

Platelet-rich plasma (PRP)

Intermediate product; platelets in plasma

Used to make concentrates

Random donor platelets (platelet concentrate)

From one whole blood unit; at least 4.5 × 10¹⁰ platelets

20–24 °C with continuous agitation for up to 5 days

Single donor platelets (apheresis)

From one donor; at least 3 × 10¹¹ platelets — equal to 6–8 random units

Same; less donor exposure

Frozen platelets

DMSO cryopreserved

Limited, special uses

  • Dose: one random donor unit raises the platelet count by about 5,000–10,000/µL. Platelets are the component most prone to bacterial contamination because they are stored warm.
4

Topic 4

Plasma components

ComparisonPlasma components
Preparation
Use

Fresh plasma

Separated and used quickly

Rarely used now

Fresh frozen plasma (FFP)

Frozen within 6–8 hours at −30 °C or colder; up to 1 year

Multiple factor deficiencies — liver disease, DIC, warfarin reversal, massive transfusion

Cryoprecipitate

FFP thawed slowly at 1–6 °C; cold-insoluble precipitate refrozen

Rich in fibrinogen, factor VIII, vWF, factor XIII, fibronectin — hypofibrinogenaemia, DIC

Cryo-poor plasma

Supernatant after cryo removal

Plasma exchange in TTP; fractionation

  • Plasma fractionation (industrial) produces albumin, immunoglobulins and factor concentrates.
5

Topic 5

Blood substitutes

  • Plasma expanders (volume replacement): crystalloids (normal saline, Ringer's lactate) and colloids (albumin, gelatin, starch, dextran) restore volume but do not carry oxygen.
  • Oxygen carriers: haemoglobin-based oxygen carriers and perfluorocarbons remain experimental or restricted. Patient blood management (treating anaemia, cell salvage, tranexamic acid) reduces transfusion needs.
6

Topic 6

Haemapheresis

  • Apheresis: blood is drawn into a cell separator, the desired component removed and the rest returned to the donor or patient.
Key termsTypes
Plateletpheresis
Single donor platelets
Leucapheresis
Granulocytes; stem cells (peripheral blood stem cell collection)
Plasmapheresis
Plasma for fractionation
Therapeutic apheresis
Plasma exchange (TTP, Guillain–Barré, myasthenia), leucodepletion in hyperleucocytosis, red cell exchange in sickle crisis
  • Complications: citrate toxicity (tingling — low ionised calcium), vasovagal reactions, vascular access problems.
7

Topic 7

Quality control in the blood bank

ComparisonQC parameters (examples)
Standard
Frequency

Packed red cells

PCV 70 ± 5% (55–65% with SAGM)

1% of units or at least 4 per month

Random donor platelets

At least 4.5 × 10¹⁰ per unit; pH 6.2 or more at expiry

1% or 4 per month

FFP

Factor VIII at least 0.7 IU/mL

Monthly

Cryoprecipitate

Factor VIII at least 80 IU and fibrinogen at least 150 mg per unit

Monthly

Leucoreduced products

Residual WBC below 5 × 10⁶ per unit

Monthly

Key termsOther QC activities
Reagents
Daily checks of antisera, AHG and reagent red cells with controls
Equipment
Temperature records of refrigerators (2–6 °C), freezers, platelet agitators; centrifuge calibration
Donor screening
Kit QC and EQAS for TTI tests
Records and traceability
Vein-to-vein tracking; regulation under the Drugs and Cosmetics Act (CDSCO licensing)

Key terms

Component therapy
Transfusing only the needed blood component
Fresh frozen plasma
Plasma frozen within hours to preserve clotting factors
Cryoprecipitate
Cold-insoluble plasma fraction rich in fibrinogen and factor VIII
Apheresis
Collection of a specific component by a cell separator
Leucoreduction
Removal of white cells from blood components

Quick revision

  • Multiple bag systems; light and heavy spins; PRP method.
  • Packed, washed, leucoreduced, irradiated, frozen red cells.
  • RDP vs SDP; 20–24 °C with agitation, 5 days.
  • FFP, cryoprecipitate, cryo-poor plasma; fractionation.
  • Plasma expanders; apheresis types and complications; QC standards and activities.

Important exam questions

Practice questions written to the PTU exam pattern for this unit's syllabus: short answers (Section A style) and long answers (Sections B and C style).

Short-answer questions

  1. Q1.At what temperature are platelets stored?
  2. Q2.Why are washed red cells given?
  3. Q3.What does cryoprecipitate contain?
  4. Q4.How long can FFP be stored?
  5. Q5.What is plateletpheresis?
  6. Q6.State the QC standard for a random donor platelet unit.

Long-answer questions

  1. Q1.Describe the preparation of blood components.
  2. Q2.Describe platelet and plasma components and their uses.
  3. Q3.Describe apheresis and quality control in the blood bank.

Stuck on this unit?

Message SBS on WhatsApp for help with Blood Banking, or to ask about studying B.Sc MLS at Synetic.

WhatsApp us